Starboard Value has nominated four directors to the board of consumer products maker Kenvue , months after the activist investor criticized lackluster performance in a core segment. Technology ...

Kenvue is exploring the sale of some of its skin health and beauty brands, four people familiar with the matter said on ...

NEW YORK (Reuters) -Kenvue is exploring the sale of some of its skin health and beauty brands, four people familiar with the matter said on Thursday, as the consumer health firm prunes an ...

Kenvue has faced shareholder pressure after activist investor Starboard Value LP took a stake last year, saying the company trades at a discount to peers such as L’Oreal SA, Procter & Gamble Co ...

Kenvue, which also makes Tylenol and Band-Aids, has faced activist pressure over the last year from Starboard Value, Toms Capital Management and Third Point.

Kenvue是2023年从强生公司（JNJ.N）分拆出来的消费品健康业务，其2023年的首次公开募股中估值约为410亿美元。根据官方网站显示，该公司共分为三个业务板块：个人健康护理、皮肤健康与美容以及基础健康。

As part of its broader restructuring efforts, Kenvue Inc. (KVUE) is considering the sale of some of its skin health and beauty brands. KVUE is currently rated a “Buy” in the portfolio, highlights Clif ...

Kenvue launched in 2022 and Aveeno, Neutrogena, Johnson’s, Tylenol and Dr.Ci:Labo are among the brands included in the consumer brand owner’s portfolio. J&J originally announced plans to separate its ...

Kenvue (NYSE:KVUE) is the largest pure-play consumer health company, spun off from Johnson & Johnson in 2023.I like the company’s iconic brands such as Tylenol, Neutrogena, Listerine, BANDAID ...

Kenvue, which also makes Tylenol and Band-Aids, has faced activist pressure over the last year from Starboard Value, Toms Capital Management and Third Point.

Kenvue, a spinoff from Johnson & Johnson, offers well-known consumer health brands and stable dividends. Investing in Kenvue is straightforward: Open a brokerage, search for KVUE stock, set an ...